Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mercachem Holding bv - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10904
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mercachem Holding BV (Mercachem) is a research company that offers transparent chemistry services. The company provides services in the areas of discovery chemistry, medicinal chemistry, parallel chemistry and process research. Its parallel chemistry services include library design, chemical validation, library synthesis and purification services. Mercachem’s process research services comprise route scouting, reaction optimization, catalyst screening, GMP production and impurity research. The company also offers optimization of lead molecules towards clinical candidates. It operates through its synthesis laboratories and analytical facility in the Netherlands. Mercachem is headquartered in Nijmegen, the Netherlands.

Mercachem Holding bv – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Partnerships 11
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Merger 16
Mercachem and Syncom Merge 16
Mercachem Holding bv – Key Competitors 17
Mercachem Holding bv – Key Employees 18
Mercachem Holding bv – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mercachem Holding bv, Pharmaceuticals & Healthcare, Key Facts 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Mercachem and Syncom Merge 16
Mercachem Holding bv, Key Competitors 17
Mercachem Holding bv, Key Employees 18
Mercachem Holding bv, Subsidiaries 19
Mercachem Holding bv, Joint Venture 19

List of Figures
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and other …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Piper Jaffray Companies:企業の戦略・SWOT・財務情報
    Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report Summary Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Wells Fargo Clearing Services LLC:企業の戦略・SWOT・財務情報
    Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nodak Electric Cooperative, Inc.:発電所・企業SWOT分析
    Nodak Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Norwegian Cruise Line Holdings Ltd. (NCLH):企業の財務・戦略的SWOT分析
    Norwegian Cruise Line Holdings Ltd. (NCLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Nuvo Pharmaceuticals Inc (NRI):企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • FLX Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The company’s pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a secon …
  • Cargill Inc:企業の戦略的SWOT分析
    Cargill Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Immunovia AB (IMMNOV):企業の製品パイプライン分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Becker Avionics, Inc.:企業の戦略・SWOT・財務情報
    Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aridis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The company’s pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its propr …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Kimal plc-医療機器分野:企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …
  • BioXcel Therapeutics Inc (BTAI):製薬・医療:M&Aディール及び事業提携情報
    Summary BioXcel Therapeutics Inc (BioXcel Therapeutics) a subsidiary of BioXcel Corp is a clinical stage biopharmaceutical company focused on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology. Its pipeline product portfolio includes BXCL501, an ad …
  • National Railroad Passenger Corporation:企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • University of Wisconsin Madison-製薬・医療分野:企業M&A・提携分析
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆